Nephrogenic Systemic Fibrosis
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in Magnetic Resonance Imaging Clinics of North America
- Vol. 17 (1), 159-167
- https://doi.org/10.1016/j.mric.2009.01.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- High-Spatial-Resolution Lower Extremity MR Angiography at 3.0 T: Contrast Agent Dose Comparison StudyRadiology, 2008
- Nephrogenic Systemic Fibrosis: A Chemical PerspectiveRadiology, 2008
- Nephrogenic Systemic FibrosisJournal of the American Society of Nephrology, 2006
- Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Nephrogenic Fibrosing Dermopathy: Suspect Identified, Motive UnclearThe American Journal of Dermatopathology, 2003
- Low-Dose Gadobenate Dimeglumine Versus Standard Dose Gadopentetate Dimeglumine for Contrast-Enhanced Magnetic Resonance Imaging of the LiverInvestigative Radiology, 2003
- Nephrogenic Fibrosing DermopathyThe American Journal of Dermatopathology, 2001
- Renal Time-resolved MR Angiography: Quantitative Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine with Different DosesRadiology, 2001
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsThe Lancet, 2000